Novavax Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	596.34	1,123	682.16	983.71	1,982	1,146
Revenue Growth (YoY)	-52.48%	64.69%	-30.65%	-50.37%	72.89%	141.02%
Cost of Revenue	89.62	73.04	202.74	343.77	902.64	-
Gross Profit	506.72	1,050	479.42	639.94	1,079	1,146
Selling, General & Admin	138.17	157.48	337.19	468.95	488.69	298.36
Research & Development	348.86	342.32	391.17	737.5	1,235	2,535
Other Operating Expenses	97.85	97.85	-	-	-	-
Total Operating Expenses	584.87	597.64	728.35	1,206	1,724	2,833
Operating Income	-78.15	452.8	-248.93	-566.51	-644.74	-1,687
Interest Expense	-21.73	-22.55	-20.08	-14.42	-19.88	-21.13
Other Non-Operating Income (Expense)	13.69	11.92	92.39	37.9	10.97	-6.83
Total Non-Operating Income (Expense)	-8.04	-10.63	72.32	23.48	-8.91	-27.96
Pretax Income	-86.19	442.17	-176.62	-543.03	-653.65	-1,715
Provision for Income Taxes	-2.08	-1.87	-10.88	-2.03	-4.29	-29.22
Net Income	-87.84	440.3	-187.5	-545.06	-657.94	-1,744
Net Income to Common	-87.84	440.3	-187.5	-545.06	-657.94	-1,744
Shares Outstanding (Basic)	163	162	152	101	78	74
Shares Outstanding (Diluted)	167	173	152	101	78	74
Shares Change (YoY)	0.64%	13.74%	51.03%	28.89%	5.08%	29.27%
EPS (Basic)	-0.54	2.72	-1.23	-5.41	-8.42	-23.44
EPS (Diluted)	-0.58	2.58	-1.23	-5.41	-8.42	-23.44
Shares Outstanding	164.42	162.58	160.42	139.51	86.04	75.84
Free Cash Flow	-97.65	-250.2	-100.32	-767.74	-504.99	268.45
Free Cash Flow Per Share	-0.58	-1.45	-0.66	-7.62	-6.46	3.61
Gross Margin	84.97%	93.50%	70.28%	65.05%	54.46%	100.00%
Operating Margin	-13.10%	40.30%	-36.49%	-57.59%	-32.53%	-147.13%
Profit Margin	-14.73%	39.19%	-27.49%	-55.41%	-33.20%	-152.12%
FCF Margin	-16.38%	-22.27%	-14.71%	-78.05%	-25.48%	23.42%
EBITDA	-55.81	480.41	-200.44	-525.29	-615.68	-1,674
EBITDA Margin	-9.36%	42.76%	-29.38%	-53.40%	-31.07%	-146.03%
EBIT	-78.15	452.8	-248.93	-566.51	-644.74	-1,687
EBIT Margin	-13.10%	40.30%	-36.49%	-57.59%	-32.53%	-147.13%
Effective Tax Rate	2.41%	-0.42%	6.16%	0.37%	0.66%	1.70%

SEC Filings: 10-K · 10-Q